In the evolving landscape of medical research, staying relevant and progressive is essential for any academic journal. With this in mind, we are excited to announce that the esteemed APMIS Journal has undergone a significant transformation. APMIS changes name to PMI Journal.
APMIS Journal has rebranded as the Journal of Pathology, Microbiology & Immunology, or The PMI Journal. We believe that this change perfectly marks the journals 100th anniversary, reflecting its commitment to modernisation and its broadened global perspective. The new name, Journal of Pathology, Microbiology & Immunology (PMI Journal), encapsulates the journal’s core focus areas, providing a clear and immediate understanding of its scope.
Interdisciplinary Excellence
The rebranding underscores our dedication to the intersection of pathology, microbiology, and immunology. These three fields are intrinsically linked and often collaborate to drive advancements in medical research. By emphasising this interdisciplinary approach, The PMI Journal positions itself as a unique platform that fosters innovation and collaboration across domains. This focus study is particularly relevant in today’s research environment, where complex medical challenges often require multifaceted solutions.
A Global Perspective
Historically, our journal’s name APMIS Journal (Acta Pathologica, Microbiologica, et Immunologica Scandinavica) included a reference to Scandinavia, reflecting its origins and initial regional focus. However, The PMI Journal has long outgrown these geographical boundaries. We now attract submissions from researchers worldwide, publishing influential articles from diverse scientific communities. This change not only broadens our appeal but also aligns with our mission to disseminate high-quality research across the globe.
Upholding Core Values
While the name has changed, The PMI Journal remains steadfast in its core values. We continue to support younger researchers for example by publishing PhD theses and mini reviews from junior scientists, providing them with a vital platform to share their work, ensuring that the next generation of researchers can contribute to the scientific community.
Moreover, The PMI Journal proudly maintains its non-for-profit status. This approach ensures that we prioritise scientific integrity and the advancement of knowledge over commercial interests and can thrive without the constraints often imposed by for-profit models. You can read more about our aims and scope here.
Celebrating a Century of Excellence
As The PMI Journal celebrates its 100th anniversary, the name change symbolises both a respect for its storied past and an ambitious vision for the future. Over the past century, we have published works from renowned researchers, contributing significantly to the fields of pathology, microbiology, and immunology – something you can read more about here.
This legacy provides a strong foundation upon which we will continue to build history to inspire future innovations. By adopting a modern identity, emphasising interdisciplinary collaboration, and embracing a global perspective, the Journal of Pathology, Microbiology & Immunology is well-positioned to continue its legacy of excellence for another century.
Your support has been key to our journey, and we hope you’ll stick with us as we continue to grow, spread, and develop the journal.
